BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15616604)

  • 1. Salmonella-mediated oral DNA vaccination using stabilized eukaryotic expression plasmids.
    Bauer H; Darji A; Chakraborty T; Weiss S
    Gene Ther; 2005 Feb; 12(4):364-72. PubMed ID: 15616604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral delivery of a DNA vaccine against tuberculosis using operator-repressor titration in a Salmonella enterica vector.
    Huang JM; Sali M; Leckenby MW; Radford DS; Huynh HA; Delogu G; Cranenburgh RM; Cutting SM
    Vaccine; 2010 Nov; 28(47):7523-8. PubMed ID: 20851079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving live attenuated bacterial carriers for vaccination and therapy.
    Loessner H; Endmann A; Leschner S; Bauer H; Zelmer A; zur Lage S; Westphal K; Weiss S
    Int J Med Microbiol; 2008 Jan; 298(1-2):21-6. PubMed ID: 17702649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells.
    Weiss S; Krusch S
    Biol Chem; 2001 Apr; 382(4):533-41. PubMed ID: 11405218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium.
    Gahan ME; Webster DE; Wesselingh SL; Strugnell RA
    Vaccine; 2007 Feb; 25(8):1476-83. PubMed ID: 17126961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.
    Darji A; zur Lage S; Garbe AI; Chakraborty T; Weiss S
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):341-9. PubMed ID: 10727890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
    Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
    Husseiny MI; Hensel M
    Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Listeria monocytogenes as novel carrier system for the development of live vaccines.
    Schoen C; Loeffler DI; Frentzen A; Pilgrim S; Goebel W; Stritzker J
    Int J Med Microbiol; 2008 Jan; 298(1-2):45-58. PubMed ID: 17936682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune response and protective efficacy in BALB/c mice induced by DNA vaccine encoding immunogenic protein of Legionella pneumophila].
    Yang ZW; Chen JP; Wang T; Tian Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):209-12. PubMed ID: 17343784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L; Kedl R; Dow S
    Cancer Gene Ther; 2006 Nov; 13(11):1033-44. PubMed ID: 16841080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced vaccine antigen delivery by Salmonella using antibiotic-free operator-repressor titration-based plasmid stabilisation compared to chromosomal integration.
    Leckenby MW; Spear AM; Neeson BN; Williamson ED; Cranenburgh RM; Atkins HS
    Microb Pathog; 2009 Apr; 46(4):201-6. PubMed ID: 19490834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice.
    Wang KY; Guo YJ; Zhang YL; Lv K; Sun SH
    Vaccine; 2007 May; 25(22):4429-36. PubMed ID: 17420075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmonella: immune responses and vaccines.
    Mastroeni P; Chabalgoity JA; Dunstan SJ; Maskell DJ; Dougan G
    Vet J; 2001 Mar; 161(2):132-64. PubMed ID: 11243685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium.
    Ning JF; Zhu W; Xu JP; Zheng CY; Meng XL
    Vaccine; 2009 Feb; 27(7):1127-35. PubMed ID: 19071178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K
    Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.